W. Roth
Impact in
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Equine top 5%
Papers in
-
- Bioactive Compounds and Antitumor Agents 1
-
- Inflammatory mediators and NSAID effects 2
- Co-authors
- Ulrich BuschJoachim StangierDominique TurckG. HeinzelJochen SchmidK BeschkeLeopold HornerAndreas Greischel
- Journals
- Journal of Pharmaceutical Sciences (2 papers)Die Naturwissenschaften (2 papers)JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY (1 paper)Lara D. Veeken (1 paper)Xenobiotica (1 paper)
- Partner nations
- GermanyUnited StatesIreland
In The Last Decade
W. Roth
14 papers receiving 597 citations
Peers
Comparison fields: 5 of 96
- Pharmacology 227
- Equine 21
- Small Animals 90
- Pharmacology 102
- Pharmaceutical Science 52
Countries citing papers authored by W. Roth
This map shows the geographic impact of W. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Roth more than expected).
Fields of papers citing papers by W. Roth
This network shows the impact of papers produced by W. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Roth. The network helps show where W. Roth may publish in the future.
Co-authorship network
The 25 scholars most cited alongside W. Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2021 | 9 | |
| 5 | 2018 | 0 | |
| 6 | 2002 | 0 | |
| 7 | 2000 | 24 | |
| 8 | 2000 | 173 | |
| 9 | Pharmacokinetics of meloxicam in animals and the relevance to humans. | 1998 | 196 |
| 10 | 1996 | 153 | |
| 11 | 1993 | 19 | |
| 12 | 1991 | 11 | |
| 13 | 1990 | 2 | |
| 14 | [Pharmacokinetics and laxative effect of bisacodyl following administration of various dosage forms]. | 1988 | 19 |
| 15 | 1987 | 3 | |
| 16 | 1984 | 16 | |
| 17 | 1977 | 15 | |
| 18 | 1976 | 6 |
About W. Roth
W. Roth is a scholar working on Toxicology, Pharmacology, Process Chemistry and Technology, Analytical Chemistry and Geriatrics and Gerontology, having authored 18 papers that have together received 647 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (3 papers), Analytical Chemistry and Chromatography (2 papers), Opioid Use Disorder Treatment (2 papers), Blood Pressure and Hypertension Studies (2 papers), Inflammatory mediators and NSAID effects (2 papers), Cardiac electrophysiology and arrhythmias (2 papers), Hormonal Regulation and Hypertension (2 papers) and Bioactive Compounds and Antitumor Agents (1 paper). The work is most often cited by research in Pharmacology (227 citations), Equine (21 citations), Small Animals (90 citations), Pharmacology (102 citations) and Pharmaceutical Science (52 citations). W. Roth has collaborated with scholars based in Germany, United States and Ireland. Frequent co-authors include Ulrich Busch, Joachim Stangier, Dominique Turck, G. Heinzel, Jochen Schmid, K Beschke, Leopold Horner, Andreas Greischel, F. ROLLA and J. H. G. Jonkman. Their work appears in journals such as Journal of Pharmaceutical Sciences, Die Naturwissenschaften, JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Lara D. Veeken and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.